Article

Diabetes program funded

Prevent Blindness America (PBA) has received a grant from the Allergan Foundation to enable the organization to develop a Spanish language version of its online Diabetic Eye Disease Educator Program.

Chicago-Prevent Blindness America (PBA) has received a grant from the Allergan Foundation to enable the organization to develop a Spanish language version of its online Diabetic Eye Disease Educator Program.

PBA launched the program for outreach personnel and allied health professionals last year with funding from the foundation. The program is designed to teach participants about the visual system and the signs, symptoms, and complications of the secondary diseases of diabetes, such as diabetic retinopathy and glaucoma. Also, the program seeks to deliver patient education messages about diabetic eye disease through health outreach programs of community health centers, health departments, and civic and faith-based organizations to those populations at highest risk for developing diabetes.

“The Allergan Foundation has been generous partner of PBA for many years, helping us to continue our mission to end preventable vision loss,” said Hugh R. Parry, the organization’s president and chief executive officer. “Thanks to [its] generous support of our diabetes education program, we can help to provide those in communities across the country the tools they need to help protect their eyes from the terrible effects of diabetes.”

For more information about the Diabetes Educator Program, visit www.preventblindness.org/diabetes or call 800/331-2020.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.